This is a preview of subscription content, log in via an institution to check access.
Notes
2016 Japanese yen
2016 British pounds
Reference
Kamagata E, et al. Improvements in Quality-Adjusted Life Years and Cost-Utility After Pharmacotherapy for Premenstrual Dysphoric Disorder: A Retrospective Study. Clinical Drug Investigation : 14 Oct 2017. Available from: URL: http://doi.org/10.1007/s40261-017-0583-3
Rights and permissions
About this article
Cite this article
Pharmacotherapy cost effective for premenstrual dysphoric disorder. PharmacoEcon Outcomes News 790, 24 (2017). https://doi.org/10.1007/s40274-017-4469-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4469-7